Cardium Therapeutics
Biotechnology Research • 
San Diego, California, United States • 1-10 Employees
Company overview
| Headquarters | 12255 El Camino Real, Suite 250, San Diego, CA 92130, US |
| Phone number | +18584141477 |
| Website | |
| Employees | 1-10 |
| Socials |
Key Contact at Cardium Therapeutics
Chris Reinhard
Founder, Chairman Of Board And Chief Executive Officer
About Cardium Therapeutics
Cardium Therapeutics is focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses that have the potential to address significant unmet medical needs and definable pathways to commercialization, partnering and other economic monetizations. Cardium’s investment portfolio includes the Tissue Repair Company and Cardium Biologics, medical technology companies primarily focused on the development of innovative therapeutic products for wound healing, bone repair, and cardiovascular indications. In May 2009, Cardium announced completion of the enrollment for the Matrix Phase 2b clinical study to evaluate the Excellarate product candidate as a treatment for patients with non-healing diabetic ulcers. In July 2009, Cardium completed the sale of its InnerCool Therapies medical device business to Royal Philips Electronics, the first asset monetization from the Company’s biomedical investment portfolio.
Cardium Therapeutics revenue & valuation
| Annual revenue | $109,200 |
| Revenue per employee | $16,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $349,440 |
| Total funding | $750,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Cardium Therapeutics has 4 employees across 4 departments.
Departments
Number of employees
Malaysia
United Kingdom
Netherlands
NigeriaFrequently asked questions
4.8
40,000 users
